Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cariou

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Diabetes, Obesity & Metabolism|March 19, 2016
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)V R Aroda, T S Bailey, B Cariou, et al.
Scientific Reports|April 14, 2021
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptomsL Quénéhervé, D Drui, J Blin, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Diabetes & Metabolism|December 19, 2015
Indicators of iron status are correlated with adiponectin expression in adipose tissue of patients with morbid obesityF Pihan-Le Bars, F Bonnet, O Loréal, et al.
Diabetes & Metabolism|October 4, 2016
One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromesC Vatier, L Arnaud, X Prieur, et al.
International Journal of Obesity (2005)|November 15, 2017
Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorptionC Blanchard, F Moreau, A Ayer, et al.
Diabetologia|May 18, 2013
Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient miceX Prieur, L Dollet, M Takahashi, et al.
Diabetes & Metabolism|March 29, 2017
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trialB Cariou, L A Leiter, D Müller-Wieland, et al.
Diabetes & Metabolism|December 16, 2019
Eating behaviours associated with glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetesA De Luca, V A Baudry, M Wargny, et al.
Diabetes & Metabolism|February 8, 2020
Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patientsC Blanchard, S Ledoux, A Verhaegen, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Diabetes, Obesity & Metabolism|March 19, 2016
Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)V R Aroda, T S Bailey, B Cariou, et al.
Scientific Reports|April 14, 2021
Digestive symptoms in daily life of chronic adrenal insufficiency patients are similar to irritable bowel syndrome symptomsL Quénéhervé, D Drui, J Blin, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Diabetes & Metabolism|December 19, 2015
Indicators of iron status are correlated with adiponectin expression in adipose tissue of patients with morbid obesityF Pihan-Le Bars, F Bonnet, O Loréal, et al.
Diabetes & Metabolism|October 4, 2016
One-year metreleptin therapy decreases PCSK9 serum levels in diabetic patients with monogenic lipodystrophy syndromesC Vatier, L Arnaud, X Prieur, et al.
International Journal of Obesity (2005)|November 15, 2017
Roux-en-Y gastric bypass reduces plasma cholesterol in diet-induced obese mice by affecting trans-intestinal cholesterol excretion and intestinal cholesterol absorptionC Blanchard, F Moreau, A Ayer, et al.
Diabetologia|May 18, 2013
Thiazolidinediones partially reverse the metabolic disturbances observed in Bscl2/seipin-deficient miceX Prieur, L Dollet, M Takahashi, et al.
Diabetes & Metabolism|March 29, 2017
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trialB Cariou, L A Leiter, D Müller-Wieland, et al.
Diabetes & Metabolism|December 16, 2019
Eating behaviours associated with glycaemic variability and fear of hypoglycaemia in adults with type 1 diabetesA De Luca, V A Baudry, M Wargny, et al.
Diabetes & Metabolism|February 8, 2020
Roux-en-Y gastric bypass, but not sleeve gastrectomy, decreases plasma PCSK9 levels in morbidly obese patientsC Blanchard, S Ledoux, A Verhaegen, et al.
Pageof 5